Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
HER2-Specific CAR T
i
Other names:
HER2-Specific CAR T
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Cellevolve Bio, Seattle Children’s Therapeutics
Drug class:
HER2-targeted CAR-T immunotherapy
Related drugs:
‹
AU-101 (0)
AU-105 (0)
BPX-603 (0)
CART-HER-2 (0)
CCT303-406 (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
HypoSti.CAR-HER2 T (0)
MB-103 (0)
RB-312 (0)
RB-340 (0)
SC-CAR4BRAIN (0)
s (0)
SCRI-huCAR19v1 (0)
SCRI-huCAR19v2 (0)
SNC109 (0)
TGFBeta resistant HER2/EBV-CTLs (0)
TT16 (0)
AU-101 (0)
AU-105 (0)
BPX-603 (0)
CART-HER-2 (0)
CCT303-406 (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
HypoSti.CAR-HER2 T (0)
MB-103 (0)
RB-312 (0)
RB-340 (0)
SC-CAR4BRAIN (0)
s (0)
SCRI-huCAR19v1 (0)
SCRI-huCAR19v2 (0)
SNC109 (0)
TGFBeta resistant HER2/EBV-CTLs (0)
TT16 (0)
›
Associations
News
Trials
Filter by
Latest
11ms
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (clinicaltrials.gov)
P1, N=10, Active, not recruiting, Seattle Children's Hospital | Recruiting --> Active, not recruiting | N=48 --> 10
11 months ago
Enrollment closed • Enrollment change
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive
|
HER2-Specific CAR T
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login